UW Health Expert in Wisconsin provides advice & information on safety amidst extreme heat
The high temperatures could cause heat-borne illnesses or other severe issues if proper steps aren't taken. Local 5 spoke with a University of Wisconsin Health expert to learn more.
Summerfest loosens water rules due to rising weekend heat for one day only
Doctor Matteo Perrone, a UW Health Family Medicine Physician, spoke to Local 5, giving insight on ways to manage the heat, emphasizing hydration.
'For a male adult, we recommend 64 ounces of fluid per day,' Dr. Perrone said. 'If you're planning on spending time outdoors, your fluid intake will have to be even higher, and if you are sweating, electrolytes will be essential.'
If people don't take steps to manage and combat the heat, serious symptoms could occur, Dr. Perrone said, with initial issues varying from dizziness and cramps.
'Dizziness, lightheadedness, cramps and fatigue are some of the initial stages when your body temperature starts to rise,' Dr. Perrone said. 'When your body temperature reaches a point that it can't regulate anymore, that's when confusion happens and you can pass out.'
Dr. Perrone emphasized that a fan won't be enough at all, as they don't help cool you off, it just gives the sensation of feeling cool without lowering the body temperature.
In a release from Emplify Health by Bellin, the same was said regarding consuming fluids and avoiding electric fans as the answer. People are recommended to stay indoors and near air conditioning, as it can help their bodies stay cool when they go out into the heat.
Due to upcoming heat wave, popular Green Bay pizza place to close for one day
While exercise is crucial to health, people should be advised to limit outdoor physical exercise. Those who choose to exercise outdoors must keep hydration levels up, especially with electrolytes, and limit activity to the morning or evening when temperatures are at their lowest.
Additionally, lightweight, loose and light-colored clothing is critical, as it reflects heat. Those who are outdoors should also consider wide-brimmed hats and sunglasses, with sunscreen marked at least SPF 15.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 days ago
- Yahoo
Lake in Wisconsin temporarily closed due to extremely high levels of E. coli
REID, Wis. (WFRV) – Swimmers and boaters are being asked to steer clear of a lake in Wisconsin after authorities detected extremely high levels of E. coli in the water on Monday. According to the Marathon County Sheriff's Office, routine water testing revealed elevated bacterial levels, prompting officials to close Mission Lake for public safety. Appleton International Airport adds nonstop flight to Fort Myers 'For your safety, Mission Lake is temporarily closed to swimming and boating,' the sheriff's office stated in a release. The Latest: Gunman targeted the NFL headquarters in Manhattan, mayor says The Marathon County Parks, Recreation & Forestry Department is conducting additional testing and working to identify the source of the contamination. The closure will remain in place until water quality improves to acceptable levels for recreational use. 'We appreciate your understanding as we work to protect public health,' county officials added. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Solve the daily Crossword
The Hill
26-07-2025
- The Hill
CDC confirms at least 85 people experienced THC sickness from pizza place in Wisconsin
STOUGHTON, Wis. (WFRV) – The Centers for Disease Control and Prevention (CDC) released a report about nine months after an incident at a Wisconsin pizza parlor where THC-infused oil was used to prepare dough. According to the report, at least 85 individuals, ranging from 1 to 91 years old, consumed food from the pizza shop in Stoughton, Wisconsin, between Oct. 22 and 24. The CDC said that the restaurant was in a building with a shared kitchen utilized by a state-licensed edible THC vendor. Initial reports came as emergency medical services in the area reported to Public Health Madison and Dane County (PHMDC) that seven people had been taken to local hospitals for symptoms such as dizziness, sleepiness and anxiety. Each individual reported eating from the same local restaurant. The seven individuals were treated at a Stoughton hospital with THC intoxication symptoms. One person who had eaten pizza from the same place reported that they had a positive THC test result without knowingly consuming any, prompting an outbreak investigation. The restaurant closed immediately on Oct. 24, confirming to PHMDC about the THC vendor in the shared kitchen. According to the CDC report, the restaurant owner confirmed that they ran out of cooking oil on Oct. 22, using some from the shared kitchen to prepare dough. Further investigation revealed that the oil used tested positive for THC, as the restaurant mistakenly used THC-infused oil from the cooperative kitchen to prepare dough. No criminal charges were filed as police deemed the contamination to be unintentional. The restaurant reopened on Oct. 26 after deep cleaning and sanitation procedures approved by the Wisconsin Food Code. The CDC report stated the following, '85 persons who responded to a health department questionnaire reported symptoms consistent with THC intoxication that occurred within 5 hours after eating food from a pizza restaurant.' The restaurant apologized for the incident after initial reports from October 2024.
Yahoo
25-07-2025
- Yahoo
Semaglutide improves brain-related injury patients' outcomes
GLP-1R agonist semaglutide, also known as Ozempic or Wegovy, has been making headlines for its potential in its original market - the treatment of Type 2 diabetes - for its weight loss effects and benefits in other metabolic disorders, and for its possible expansions into new therapeutic areas. Most recently, results from different studies have suggested that semaglutide may improve patient outcomes following brain haemorrhage or stroke. GlobalData estimates that semaglutide's benefits may be connected to a reduction of inflammation in the body and brain. As mentioned in GlobalData's report: GLP-1R Agonist - Label Expansions/Drug Repurposing: Market Overview, Ozempic is currently in Phase II trials for acute ischaemic stroke. Other GLP-1R agonists and combination therapies are in clinical development for other neurological conditions, and many academic studies are currently focusing on the potential use of GLP-1R agonists in stroke to reduce complications and the risk of recurrence altogether. In July 2025, new results have emerged from three studies investigating the use of semaglutide in stroke and brain haemorrhage patients. A study by the University of Wisconsin-Madison revealed that the chance of surviving after a stroke was higher in patients on semaglutide, and death from stroke was more frequent in the patient group not on a GLP-1R agonist. Another study by the same university examining a US nationwide sample of hospital records found an association between the use of GLP-1R agonists and a reduction in stroke complications. A third study by the University of Texas Medical Branch in Galveston suggested that semaglutide use was linked to a reduced risk of side effects, seizures, future recurrence and death after brain haemorrhage and stroke. The SELECT trial has demonstrated a clear cardiovascular protection associated with semaglutide use, which could explain its benefits in stroke patients. Furthermore, the occurrence of stroke is linked to metabolic health, inflammation and obesity, so an improvement in these factors can benefit patients likely to experience a stroke or who have done so in the past. According to key opinion leaders interviewed by GlobalData, the potential of GLP-1R agonists in brain diseases seems to be based on their anti-inflammatory action. Indeed, GLP-1R agonists are known to improve insulin sensitivity and reduce insulin resistance, and it seems that this translates to the brain too, as these molecules can cross the blood-brain barrier. Cerebrovascular conditions such as stroke and brain hemorrhage appear to benefit from both the cardiovascular benefits and cerebral anti-inflammatory health benefits associated with GLP-1R agonists' use, on top of the improvement in overall health. Therefore, GLP-1R agonists may successfully penetrate not one but multiple neurological diseases markets, if their effects are proven to be significant and worth the cost of these medicines. "Semaglutide improves brain-related injury patients' outcomes" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
